Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Jason A Keyes Insider Profile

4 Followers

Jason A Keyes, Chief Financial Officer at BlossomHill Therapeutics, Inc., holds 700.00 shares in BlossomHill Therapeutics, Inc. (Ticker: BLSM), holds 126.63K shares in Equillium (Ticker: EQ), holds 40.00K shares in Carisma Therapeutics (Ticker: CARM). Most recently, Jason A Keyes Bought ― shares of BlossomHill Therapeutics, Inc. on Aug 10, 2026 for an estimated value of $11.20K.

Jason A Keyes's Trading History

BLSMBlossomHill Therapeutics, Inc.		Aug 10, 2026Chief Financial OfficerInformative Buy11.20K$9.63K
EQEquillium		Jan 24, 2025CFOUninformative Sell6.50K$173.49K
CARMCarisma Therapeutics		Jun 24, 2022DirectorUninformative Buy―$400.00
OREXQOrexigen		Jun 02, 2017―Uninformative Buy863.35$109.16
ACTUActuate Therapeutics, Inc.		―Director――
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Jason A Keyes insider profile FAQ

What stocks does Jason A Keyes hold?
Jason A Keyes holds: BLSM, OREXQ, CARM, EQ, ACTU stocks.
What was Jason A Keyes’s latest transaction?
Jason A Keyes’s latest transaction was an Informative Buy of $11.20K.
What is Jason A Keyes's role in BlossomHill Therapeutics, Inc.?
Jason A Keyes's role in BlossomHill Therapeutics, Inc. is Chief Financial Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.